You are here

  • Home
  • Archive
  • Volume 31, Issue 2
  • Determination of plasma uracil as a screening for dihydropyrimidine dehydrogenase deficiency: clinical application in oncological treatments

Article metrics

Article menu
Download PDFPDF
Original research
Determination of plasma uracil as a screening for dihydropyrimidine dehydrogenase deficiency: clinical application in oncological treatments

 

Online download statistics by month:

Online download statistics by month: June 2022 to March 2024

AbstractFullPdf
Jun 2022685238
Jul 202242530
Aug 202227321
Sep 202232062
Oct 202239330
Nov 202229572
Dec 202231933
Jan 202328512
Feb 202315600
Mar 202321511
Apr 202314600
May 202313510
Jun 202321201
Jul 202320500
Aug 202314412
Sep 202315011
Oct 202322200
Nov 20239330
Dec 20238900
Jan 20246114
Feb 202431632
Mar 202439177
Total55306636